Leuphasyl (a pentapeptide, meaning a chain of five amino acids: Tyr-D-Ala-Gly-Phe-Leu) is a lab-made copy of an enkephalin (one of the body's natural pain-calming chemicals). It attaches to opioid receptors (docking sites) on the sending end of the nerves that control muscles. This switches on inhibitory G-proteins (Gi, cell switches that turn activity down). Gi shuts down adenylyl cyclase (an enzyme), which lowers cAMP (an internal cell signal) and closes L-type calcium channels (gates that let calcium in). Without calcium coming in, the nerve cannot release its packets of acetylcholine (the chemical that tells a muscle to contract). This is different from acetyl hexapeptide-3 (Argireline), which works at a later step (called postsynaptic) by blocking SNARE complex formation (the protein machinery that lets those packets fuse and release). Because the two work at different steps, they team up. Leuphasyl blocks acetylcholine release early, at the nerve's sending end (presynaptic). Argireline blocks packet fusion later (postsynaptic). Together they produce about 25% wrinkle reduction, compared with 11% for Leuphasyl alone or about 15% for Argireline alone at the same concentrations.